Cargando…

A Comprehensive Evaluation of Cross-Omics Blood-Based Biomarkers for Neuropsychiatric Disorders

The identification of peripheral multi-omics biomarkers of brain disorders has long been hindered by insufficient sample size and confounder influence. This study aimed to compare biomarker potential for different molecules and diseases. We leveraged summary statistics of five blood quantitative tra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Weichen, Wang, Weidi, Liu, Zhe, Cai, Wenxiang, Yu, Shunying, Zhao, Min, Lin, Guan Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703948/ https://www.ncbi.nlm.nih.gov/pubmed/34945719 http://dx.doi.org/10.3390/jpm11121247

Ejemplares similares

Mendelian randomization studies of brain MRI yield insights into the pathogenesis of neuropsychiatric disorders
por: Song, Weichen, et al.
Publicado: (2021)

Dissection of the Genetic Association between Anorexia Nervosa and Obsessive–Compulsive Disorder at the Network and Cellular Levels
por: Song, Weichen, et al.
Publicado: (2021)

A Comprehensive Study of De Novo Mutations on the Protein-Protein Interaction Interfaces Provides New Insights into Developmental Delay
por: Maharjan, Dhruba Tara, et al.
Publicado: (2022)

Omics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric Disorders
por: Sethi, Sumit, et al.
Publicado: (2015)

Spatiotemporal 7q11.23 protein network analysis implicates the role of DNA repair pathway during human brain development
por: Chen, Liang, et al.
Publicado: (2021)

PsyMuKB: An Integrative De Novo Variant Knowledge Base for Developmental Disorders
por: Lin, Guan Ning, et al.
Publicado: (2019)

Mendelian Randomization and GWAS Meta Analysis Revealed the Risk-Increasing Effect of Schizophrenia on Cancers
por: Yuan, Kai, et al.
Publicado: (2022)

De novo mutations identified by whole-genome sequencing implicate chromatin modifications in obsessive-compulsive disorder
por: Lin, Guan Ning, et al.
Publicado: (2022)

Inferring the Effects of Protein Variants on Protein–Protein Interactions with Interpretable Transformer Representations
por: Liu, Zhe, et al.
Publicado: (2023)

Spatiotemporal 22q11.21 Protein Network Implicates DGCR8-Dependent MicroRNA Biogenesis as a Risk for Late Fetal Cortical Development in Psychiatric Diseases
por: Chen, Liang, et al.
Publicado: (2021)

An Integrative Analysis of Identified Schizophrenia-Associated Brain Cell Types and Gene Expression Changes
por: Cai, Wenxiang, et al.
Publicado: (2022)

Editorial: Glutamate-Related Biomarkers for Neuropsychiatric Disorders
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Integrative enrichment analysis of gene expression based on an artificial neuron
por: Jiang, Xue, et al.
Publicado: (2021)

Apolipoprotein D as a Potential Biomarker in Neuropsychiatric Disorders
por: del Valle, Eva, et al.
Publicado: (2023)

Alternatively Splicing Interactomes Identify Novel Isoform-Specific Partners for NSD2
por: Wang, Weidi, et al.
Publicado: (2021)

A comparison framework and guideline of clustering methods for mass cytometry data
por: Liu, Xiao, et al.
Publicado: (2019)

Cross-Disorder Analysis of De Novo Mutations in Neuropsychiatric Disorders
por: Li, Kuokuo, et al.
Publicado: (2021)

Noteworthy perspectives on microglia in neuropsychiatric disorders
por: Zhu, Hongrui, et al.
Publicado: (2023)

Editorial: The heterogeneity of neuropsychiatric disorders
por: Wu, Zhao-Min, et al.
Publicado: (2023)

Identification of Biomarkers in Neuropsychiatric Disorders Based on Systems Biology and Epigenetics
por: Peedicayil, Jacob
Publicado: (2019)

Olfactory dysfunction as a common biomarker for neurodegenerative and neuropsychiatric disorders
por: Slabik, David, et al.
Publicado: (2022)

Reelin and Neuropsychiatric Disorders
por: Ishii, Kazuhiro, et al.
Publicado: (2016)

Autoantibodies in Neuropsychiatric Disorders
por: Hoffmann, Carolin, et al.
Publicado: (2016)

The genetics of neuropsychiatric disorders
por: Bray, Nicholas J., et al.
Publicado: (2018)

Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder
por: Xu, Haiting, et al.
Publicado: (2023)

Expression alteration of microRNAs in Nucleus Accumbens is associated with chronic stress and antidepressant treatment in rats
por: Song, Weichen, et al.
Publicado: (2019)

Blood-based candidate biomarkers of the presence of neuropsychiatric systemic lupus erythematosus in children
por: Brunner, Hermine I, et al.
Publicado: (2014)

OmicsEV: a tool for comprehensive quality evaluation of omics data tables
por: Wen, Bo, et al.
Publicado: (2022)

De novo Mutations From Whole Exome Sequencing in Neurodevelopmental and Psychiatric Disorders: From Discovery to Application
por: Wang, Weidi, et al.
Publicado: (2019)

Exosomes as Emerging Biomarker Tools in Neurodegenerative and Neuropsychiatric Disorders—A Proteomics Perspective
por: Mathew, Boby, et al.
Publicado: (2021)

Fatty acids and neuropsychiatric disorders
por: Puri, Basant K
Publicado: (2008)

Maintenance Pharmacotherapies for Neuropsychiatric Disorders
por: Richards, Stephanie
Publicado: (2013)

Neuropsychiatric disorders in Cushing's syndrome
por: Pivonello, Rosario, et al.
Publicado: (2015)

Epigenetic Regulations in Neuropsychiatric Disorders
por: Kuehner, Janise N., et al.
Publicado: (2019)

Neuropsychiatric disorders and COVID-19
por: Charlton, Elizabeth, et al.
Publicado: (2021)

Neuropsychiatric disorders and COVID-19
por: Finsterer, Josef
Publicado: (2021)

Neuropsychiatric disorders and COVID-19
por: Burchill, Ella, et al.
Publicado: (2021)

The Histaminergic System in Neuropsychiatric Disorders
por: Cheng, Li, et al.
Publicado: (2021)

Gut Bacteria and Neuropsychiatric Disorders
por: Dicks, Leon M. T., et al.
Publicado: (2021)

Gut microbiome in neuropsychiatric disorders
por: MEJÍA-GRANADOS, Diana Marcela, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l4onfunqe90ddkhe6rdemtr05s